Recent Healthcare RE M&A: Welltower, Janus Living

Introduction

Healthcare real estate M&A in 2025 told a single, unmistakable story: the largest owners rotated their capital decisively into operating senior housing and out of nearly everything else. The clearest expression was Welltower's announcement of roughly $23 billion of transactions, a package that simultaneously bought senior housing and sold the outpatient medical portfolio that had long been a core holding. Around that centerpiece sat a string of take-privates, cross-border portfolio acquisitions, and, in a telling reversal, Healthpeak's decision to spin out a dedicated senior housing vehicle to re-enter a business it had earlier exited. Read together, the deals were not a collection of opportunistic trades but a coordinated bet that the senior housing demographic wave is strong enough to justify reshaping entire balance sheets around it. For a banker, the year is a case study in how conviction about a demand theme translates into concrete M&A and capital-markets activity.

The defining transaction of the year was Welltower's late-2025 announcement of about $23 billion of activity built around a single strategic idea: concentrate the portfolio in rental housing for the aging population. The package combined roughly $14 billion of senior housing acquisitions, closed or under contract, with a $7.2 billion divestiture of an 18 million square foot outpatient medical portfolio, sold in tranches through mid-2026 with a first $2 billion tranche closing in October 2025.

The acquisition side included a £5.2 billion (roughly $6.9 billion) portfolio operated by Barchester in the United Kingdom, and about $4 billion of US assets totaling roughly 12,000 units across 150 communities, including trophy East Coast communities. The scale and the willingness to fund it by divesting medical office made the rotation impossible to miss.

Welltower's appetite extended well beyond the headline package. In early 2025 it agreed to take NorthStar Healthcare Income private for $3.03 per share, an all-cash deal with an enterprise value near $900 million for a 40-community senior housing portfolio, which it planned to allocate to a newly launched funds management business. Separately, it agreed to acquire a portfolio of 38 ultra-luxury senior housing communities and nine development parcels in Canada for aggregate consideration of about C$4.6 billion.

Take-private

An acquisition in which a buyer purchases all the public shares of a listed company and removes it from the stock exchange, leaving it privately held. In healthcare real estate, take-privates let acquirers buy entire portfolios at once, often at a premium to a depressed share price, and fold them into a larger platform or a private fund vehicle.

The move into funds management is a meaningful strategic shift. By raising third-party capital to buy assets and earning fees alongside its own returns, a REIT can grow assets under management far faster than its own balance sheet would allow, capturing acquisition opportunities even when issuing its own equity would be dilutive. Allocating the NorthStar portfolio to a new funds management vehicle let Welltower add scale and a fee stream at once, and it signals that the largest REITs increasingly see themselves as capital allocators and operating platforms rather than simple balance-sheet owners. Take-privates feed that model well: they deliver an entire portfolio in one transaction, often at a premium to a depressed public share price that still represents a discount to the underlying real estate, and the buyer can then distribute the assets across its own balance sheet and its managed funds.

The geographic reach of the 2025 deals was as notable as their size. Welltower's £5.2 billion Barchester acquisition planted a major flag in the United Kingdom, and its Canadian ultra-luxury portfolio extended the push north, so that the senior housing rotation was explicitly multinational rather than US-only. The logic is that the demographic thesis driving US senior housing, an aging population meeting constrained supply, repeats across the UK, Canada, and continental Europe, even though the lease conventions, regulatory regimes, and operator markets differ by country. US REITs are increasingly comfortable underwriting that thesis abroad, a trend explored in cross-border senior housing. The cross-border expansion adds currency and local-structure complexity, but it also widens the runway for the same operating bet the REITs are making at home.

The most telling deal came from the REIT that had bet against senior housing. Healthpeak, having earlier exited senior housing to concentrate on outpatient medical and laboratory space, announced the formation of Janus Living, a spin-off launching with 34 senior housing communities and a pipeline of roughly $675 million of investments already under signed letters of intent or purchase agreements. The vehicle is built to acquire and develop communities under RIDEA management structures, the same operating model Welltower and Ventas had been racing to expand.

A REIT reversing a deliberate strategic exit is a strong signal. Healthpeak had concluded years earlier that senior housing operating risk was not worth it; its decision to re-enter through a dedicated vehicle says the operating opportunity had become too large to keep ignoring, even for the one member of the Big Three that had walked away. Structuring the re-entry as a separate spin-off rather than folding the communities back into the core portfolio also let Healthpeak give the senior housing business its own currency, management focus, and growth pipeline, while keeping its existing medical-office and lab platform distinct. The form of the deal, a dedicated vehicle built explicitly for RIDEA acquisitions, underscores that this was a considered strategic re-entry rather than an opportunistic dabble.

Taken together, the 2025 transactions point in one direction: the sector is rotating from defensive, net-lease and medical-office exposure toward direct operating exposure to senior housing through RIDEA structures. The logic is consistent across the deals.

The activity is also self-reinforcing through the capital markets. The REITs leading the rotation trade at premium valuations for their senior housing growth, which lowers their cost of capital and lets them fund acquisitions accretively, a feedback loop explored in the Big Three's divergent valuations. A REIT trading well above net asset value can issue equity and buy senior housing in a way a discounted peer cannot, which concentrates the deal activity among the strongest players.

Strip the individual deals away and 2025 reads as one coordinated move: the largest owners rotated capital out of stable, lower-growth assets and into operating senior housing, with Welltower's roughly $23 billion shift out of medical office and into senior housing as the clearest single expression, take-privates and cross-border deals reinforcing it, and even Healthpeak reversing course through the Janus Living spinoff. What makes the rotation self-reinforcing is the capital-markets loop: the REITs leading it trade at premium valuations for their senior housing growth, which lowers their cost of capital and lets them issue equity and buy accretively in a way discounted peers cannot, concentrating the activity among the strongest players. The deals are not a list to memorize but the current proof that the demographic thesis is being expressed through real transactions, and that the market is paying the firms executing it to keep going.